Dept. of Surgery, Sahlgrenska University Hospital/Ostra
Gothenburg, SE 416 85, Sweden
Location status: Recruiting
NCT Number: NCT04130971
All adult patients with colorectal cancer presenting within the Sahlgrenska University Hospital or treated at any time at Sahlgrenska University Hospital are eligible and will be asked to participate. We already have biopsies taken at surgery in patients that receive surgery, but this study will include all patients and the biopsies will be taken during endoscopy for diagnosis of the primary tumour. Biopsies will then be taken during follow-up exams prior surgery but after neoadjuvant treatment. Biopsies will also be taken during surgery and in cases where surgery is not necessary biopsies will be taken regularly during follow-up exams.
Blood samples and in relevant cases urinary samples and mouth swabs will be taken at all timepoints when biopsies are taken. If it is not possible to take biopsies prior treatment blood samples will still be drawn.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Gothenburg, SE 416 85, Sweden
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No intervention, just observation of the differences between groups and within patients.
Time frame: 1-2 months after initiated treatment
Tumour microenviroment changes
Time frame: 1month -3 years after treatment
Extra cellular matrix changes
Contact information is provided by the study sponsor or research team.
Sahlgrenska University Hospital
Other
Predict - a Translational Study to Predict Tumour Response to Neoadjuvant Treatment
Acronym: Predict
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04222413
Advanced Breast Cancer, Advanced Solid Tumors
Fairway, Kansas, United States
View Trial DetailsNCT01915225
Adenocarcinoma, Bile Duct Cancer
Bethesda, Maryland, United States
View Trial DetailsNCT05253651
Colonic Diseases, Colorectal Neoplasms
Glendale, Arizona, United States
View Trial DetailsNCT06131840
Bronchial Neoplasms, Carcinoma, Bronchogenic
Phoenix, Arizona, United States
View Trial Details